tiprankstipranks
Trending News
More News >
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market
Advertisement

Jasper Therapeutics (JSPR) Drug Pipeline

Compare
1,022 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Briquilimab
Urticaria Chronic
Phase II
Enrolling By Invitation
A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials
Nov 20, 2024
Briquilimab
Allergic Asthma
Phase I
Terminated
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Sep 06, 2024
Briquilimab
Chronic Inducible Urticaria
Phase I/II
Terminated
A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- Antihistamines
Apr 03, 2024
Briquilimab
Chronic Spontaneous Urticaria
Phase I/II
Recruiting
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
Nov 21, 2023
Jsp191
Lower-Risk Myelodysplastic Syndrome
Phase I
Terminated
JSP191 (briquilimab) in Subjects with LR-MDS
Jun 05, 2023
Humanized Anti-Cd117 Monoclonal Antibody (Jsp191)
Scid
Phase I/II
Terminated
JSP191 Antibody Targeting Conditioning in SCID Patients
Nov 02, 2016

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Jasper Therapeutics (JSPR) have in its pipeline
      JSPR is currently developing the following drugs: Briquilimab, Briquilimab, Briquilimab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis